tirzepatide updates today Big update in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA-approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ Circle - 🚨URGENT UPDATE: Compounded

Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer

It helps improve blood-sugar control by supporting insulin release when glucose levels are elevated, reducing excess glucagon release, slowing stomach emptying, and regulating appetite

Here's why that combination is interesting: rapamycin inhibits mTOR, the cellular growth pathway that, when chronically overactivated, drives cellular senescence in follicle stem cell niches

Measurable weight loss typically begins within the first month, with an average of 9 pounds lost in the first four weeks according to patient reports

Protective effect of berberine in diabetic nephropathy: A systematic review and meta-analysis revealing the mechanism of action

Always check the expiration date or beyond-use date on the vial before using the medication to ensure its still safe and effective.